LIFESCI VENTURE PARTNERS
LifeSci Venture Partners is an early-stage investment firm that invests in early-stage life sciences and healthcare companies. The firm provides companies in the life sciences industry with comprehensive solutions to communications and investor outreach. Their investment principals have broad-ranging life sciences experience including public and private investing, deal structuring, investment banking, equity capital markets, equity research, and bench research both basic science and applied.
LIFESCI VENTURE PARTNERS
Industry:
Health Care Life Science Venture Capital
Founded:
2017-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Scribble Ventures
Scribble Ventures is an early-stage investment fund that focuses on Pre-Seed through Series A.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-10 | MOMA Therapeutics | LifeSci Venture Partners investment in Series B - MOMA Therapeutics | 150 M USD |
| 2022-02-17 | Beta Bionics | LifeSci Venture Partners investment in Series C - Beta Bionics | 57 M USD |
| 2022-01-19 | Ceptur Therapeutics | LifeSci Venture Partners investment in Series A - Ceptur Therapeutics | 75 M USD |
| 2021-11-03 | Antios Therapeutics | LifeSci Venture Partners investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-11-03 | Clade Therapeutics | LifeSci Venture Partners investment in Series A - Clade Therapeutics | 87 M USD |
| 2021-10-07 | Science 37 | LifeSci Venture Partners investment in Post-IPO Equity - Science 37 | 200 M USD |
| 2021-06-15 | RayzeBio | LifeSci Venture Partners investment in Series C - RayzeBio | 108 M USD |
| 2021-04-12 | Antios Therapeutics | LifeSci Venture Partners investment in Series B - Antios Therapeutics | 96 M USD |
| 2021-03-30 | Omega Therapeutics | LifeSci Venture Partners investment in Series C - Omega Therapeutics | 126 M USD |
| 2021-03-30 | Pyxis Oncology | LifeSci Venture Partners investment in Series B - Pyxis Oncology | 152 M USD |